Welcome to our advanced, state of the art world of Nuclear/Molecular imaging.
The section of Nuclear/Molecular Imaging at McGovern Medical School performs a wide spectrum of diagnostic and therapeutic studies, these include general nuclear medicine studies, oncologic and neurologic PET imaging. We also provide thyroid disorders and thyroid cancer therapies, prostate cancer metastases to bone therapy and primary liver cancer or liver metastases therapy. We use radioactive isotopes in trace amounts to diagnose and treat a wide variety of disorders. All our diagnostic studies have no side effects. Our therapy procedures may have minimal to no side effects.
Our staff includes 3 experienced nuclear medicine physicians and a nuclear medicine manager with a Bachelors Degree in Science. Our team is active in research and teaching of radiology residents. We also have mini-PET fellowship consisting of a comprehensive 2-day course in PET training which provides the mentored reading of 150 PET cases.
What is molecular imaging and how does it help people with cancer?
Molecular imaging is a type of medical imaging that provides detailed pictures of what is happening inside the body at the molecular and cellular level.
Molecular imaging offers unique insights into the human body that enable physicians to personalize patient care. In terms of diagnosis, molecular imaging is able to:
- Provide information that is unattainable with other imaging technologies or that would direct to more invasive procedures such as biopsy or surgery
- Identify disease in its earliest stages and determine the exact location of a tumor, often before symptoms occur or abnormalities can be detected with other diagnostic tests
As a tool for evaluating and managing the care of patients, molecular imaging studies help physicians:
- determine the extent or severity of the disease, including whether it has spread elsewhere in the body
- select the most effective therapy based on the unique biologic characteristics of the patient and the molecular properties of a tumor or other disease
- accurately assess the effectiveness of a treatment regimen
- adapt treatment plans quickly in response to changes in cellular activity
- assess disease progression
- identify recurrence of disease and help manage ongoing care
For more information click here, Society of Nuclear Medicine and Molecular Imaging.
Molecular Imaging at McGovern Medical School at UTHealth